Mobile Diagnostics Without Compromise
Mobile Diagnostics Delivered
Informing critical diagnostics at the earliest point of patient interaction
Clinical Intervention When Time Matters
Empowering critical treatment and care pathway decisions
Meeting Unmet Challenges
Delivering hand-held, multiplex immunoassay from a single sample
The Challenges are Global
Clinicians need critical diagnostics earlier to empower the best, actionable care pathways.
The Value is Real
Empowered clinicians give millions the opportunity of timely treatment and improved patient outcomes.
Is to bring trusted diagnostics to the point of initial patient interaction, to expand access of quality healthcare to new settings, no matter where that patient interaction occurs
The Nanōmix eLab® System
Fast and Fully Automated Hand-held, Mobile Point-of-Care System
CRITICAL INFECTION INFORMATION IN 11 MINUTES*
Timely Host Response Diagnostics for SEPSIS and Pneumonia
Make Mobile Diagnostics Without Compromise a Reality
*The Nanōmix eLab® S1 Panel for Critical Infection has received CE Mark; other assays in development and regulatory review.
The Company’s common shares begin trading on the OTC Market under the NNMX ticker symbol as of the opening of the Market today.
Critical Host Response Diagnostics in Minutes. Hand-held, Multiplex Immunoassay from a Single Sample.
"We are excited to move forward under this new structure with Nanomix’s complete organization and assets..."